Peñas, Beatriz

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Journal Article

Nicoară-Farcău, Oana; Lozano, Juan Jose; Alonso, Cristina; Sidorova, Julia; Villanueva, Càndid; Albillos, Augustín; Genescà, Joan; Llop, Elba; Calleja, Jose Luis; Aracil, Carles; Bañares, Rafael; Morillas, Rosa; Poca, Maria; Peñas, Beatriz; Augustin, Salvador; Tantău, Marcel; Thompson, Marcos; Perez-Campuzano, Valeria; Baiges, Anna; Turon, Fanny; ... (2023). Metabolomics as a tool to predict the risk of decompensation or liver related death in patients with compensated cirrhosis. Hepatology, 77(6), pp. 2052-2062. Wiley 10.1097/HEP.0000000000000316

Garcia Garcia de Paredes, Ana; Villanueva, Càndid; Blanco, Carolina; Genescà, Joan; Manicardi, Nicolo; Garcia-Pagan, Juan Carlos; Calleja, Jose Luis; Aracil, Carlos; Morillas, Rosa M; Poca, Maria; Peñas, Beatriz; Augustin, Salvador; Abraldes, Juan G; Alvarado, Eldimar; Royo, Félix; Garcia-Bermejo, Maria Laura; Falcon-Perez, Juan Manuel; Bañares, Rafael; Bosch, Jaime; Gracia-Sancho, Jordi; ... (2021). Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. JHEP reports, 3(6), p. 100368. Elsevier 10.1016/j.jhepr.2021.100368

Villanueva, Càndid; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Brujats, Anna; Calleja, José L; Aracil, Carles; Bañares, Rafael; Morillas, Rosa M; Poca, María; Peñas, Beatriz; Augustin, Salvador; Abraldes, Juan G; Alvarado, Edilmar; Torres, Ferran; Bosch, Jaime (2021). Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. Journal of hepatology, 75(3), pp. 589-599. Elsevier 10.1016/j.jhep.2021.04.022

Villanueva, Càndid; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Calleja, José L; Aracil, Carles; Bañares, Rafael; Morillas, Rosa M; Poca, María; Peñas, Beatriz; Augustin, Salvador; Abraldes, Juan G; Alvarado, Edilmar; Torres, Ferran; Bosch, Jaime (2019). β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. The lancet, 393(10181), pp. 1597-1608. Elsevier 10.1016/S0140-6736(18)31875-0

This list was generated on Thu Nov 21 16:53:25 2024 CET.
Provide Feedback